ANI Pharmaceuticals Inc (NASDAQ: ANIP) stock enjoyed a major increase of 13.4% on 2/28/25. The shares closed at $61.89. Moreover, this advance was accompanied by exceptionally high trading volume at 346% of normal. Relative to the market the stock has been weak over the last nine months but has risen 3.7% during the last week.
Current PriceTarget Research Rating
ANI Pharmaceuticals has a current Value Trend Rating of D (Negative). This VT Rating improved in recent days from D previously. This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. ANI Pharmaceuticals has a neutral Appreciation Score of 57 but a poor Power Rating of 28, and the Negative Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment